As cannabis products become more widely available, many people continue to view cannabis as a low-risk or even therapeutic for managing health symptoms such as anxiety, pain, and sleep difficulties. However, growing evidence suggests that today's high-potency cannabis products may carry significant risks for cognitive health, mental health, and the development of cannabis use disorder. As researchers work to better understand these risks, there is also increasing interest in

Despite significant advances in the treatment of substance use disorders, effective treatment options remain limited for certain substances, including methamphetamine and cocaine. As researchers continue to explore new approaches, neuromodulation has emerged as a promising strategy that may complement existing behavioral and medication-based treatments by targeting the brain circuits involved in addiction. In this Ask the Expert video, Dr. James Mahoney, Associate Professor,